Conditions are getting a bit more challenging for the drugmaker.

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Researchers at Boston-based Harvard Medical School and Brigham and ... Use of the weight loss drug was also linked to shorter hospital stays. Eli Lilly and Novo Nordisk are the main players in the GLP ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...

Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...

Seeking ways to improve the safety of anti-amyloid antibodies, John Sims of Eli Lilly & Company presented a simple option to do so for donanemab at this year’s Clinical Trials on Alzheimer’s Disease ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Commenting for Medscape Medical News, Reisa Sperling, MD, professor of neurology, Harvard Medical School, and director, ...

SimBioSys®, a pioneering TechBio company at the forefront of digital precision medicine for cancer care, is proud to announce its second FDA 510(k) clearance for TumorSight™ Viz to expand its use by ...

The heat has been out of the life sciences market over the last 18 months, but new VC investments could fuel a comeback for ...